Back to top
   Call Me Free Send SMS Send Inquiry


Product Details:


Product Description

NATCO RECEIVES GENERIC SOFOSBUVIR  APPROVAL FOR INDIA Hyderabad, India, March 12th, 2015 Natco Pharma Limited (NSE: NATCOPHARM; BSE: 524816) is pleased to announce that it is the 1st company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India). Sofosbuvir is a medicine used for chronic hepatitis C infection and sold globally by Gilead Sciences, Inc.,Natco plans to price its generic medicine at an MRP of INR 19,900 for a bottle of 28 tablets and expects to launch in India very soon. Natco had recently signed a non-exclusive licensing agreement with Gilead Sciences, to manufacture and sell generic versions of its chronic hepatitis C medicines in 91 developing countries.
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Sofosbuvir Tablets' category

Delhi, India
5A/7, Ground Floor, Ansari Road, Darya Ganj,Delhi - 110002, India
Phone :08045803825
Mr Kamal A Jindal (Director)
Mobile :08045803825
Direct No. : +919899980831